PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 67 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $257,500 | +1.8% | 25,000 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $253,000 | +0.8% | 25,000 | 0.0% | 0.02% | +25.0% |
| Q2 2022 | $251,000 | +0.4% | 25,000 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $250,000 | +0.8% | 25,000 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $248,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sea Otter Advisors LLC | 124,500 | $1,256,000 | 2.63% |
| Lynwood Capital Management Inc. | 39,615 | $400,000 | 0.44% |
| METEORA CAPITAL, LLC | 164,721 | $1,662,000 | 0.42% |
| Sage Rock Capital Management LP | 183,998 | $1,857,000 | 0.41% |
| HGC Investment Management Inc. | 500,000 | $5,045,000 | 0.34% |
| MMCAP International Inc. SPC | 370,000 | $3,733,000 | 0.30% |
| Bulldog Investors, LLP | 97,364 | $982,000 | 0.29% |
| Atalaya Capital Management LP | 200,000 | $2,020,000 | 0.27% |
| Context Capital Management, LLC | 400,000 | $4,036,000 | 0.27% |
| PERISCOPE CAPITAL INC. | 752,259 | $7,590,000 | 0.22% |